Skip to main content

Articles

Page 8 of 70

  1. Children report that they do not participate in their healthcare as much as they want, despite having the lawful right to form their own views and the right to express those views freely in all matters affecti...

    Authors: Veronica Lundberg, Catharina Eriksson, Torbjörn Lind, Imelda Coyne and Anncristine Fjellman-Wiklund
    Citation: Pediatric Rheumatology 2021 19:156
  2. Intra-articular venous malformations (IAVM) are rare benign vascular anomalies that usually affect young patients and most common locate in the knee. The terminology of these lesions is still ill-defined, as t...

    Authors: Federico Diomeda, Maria Santaniello, Giulia Bracciolini, Angelo Ravelli and Adele Civino
    Citation: Pediatric Rheumatology 2021 19:153
  3. Juvenile Idiopathic Arthritis (JIA) requires complex care that generate elevated costs, which results in a high economic impact for the family. The aim of this systematic review was to collect and cluster the ...

    Authors: Fernando García-Rodríguez, Augusto Gamboa-Alonso, Sol Jiménez-Hernández, Lucero Ochoa-Alderete, Valeria Alejandra Barrientos-Martínez, Neri Alejandro Alvarez-Villalobos, Gabriela Andrea Luna-Ruíz, Ingris Peláez-Ballestas, Ana Victoria Villarreal-Treviño, Manuel Enrique de la O-Cavazos and Nadina Rubio-Pérez
    Citation: Pediatric Rheumatology 2021 19:152
  4. The aim of the study was to investigate the relationship between the severity of typical clinical symptoms, severity of histopathological lesions in kidney biopsies in IgA vasculitis nephritis (IgAVN) and to p...

    Authors: Małgorzata Mizerska-Wasiak, Agnieszka Turczyn, Karolina Cichoń-Kawa, Jadwiga Małdyk, Monika Miklaszewska, Dorota Drożdż, Beata Bieniaś, Przemysław Sikora, Magdalena Drożyńska-Duklas, Aleksandra Żurowska, Maria Szczepańska and Małgorzata Pańczyk-Tomaszewska
    Citation: Pediatric Rheumatology 2021 19:150
  5. Chronic anterior uveitis is a sight-threatening complication of juvenile idiopathic arthritis (JIA) and a primary contributor to long-term morbidity in people with JIA. Levels of knowledge about uveitis among ...

    Authors: Ashley M. Cooper, Elaine R. Flanagan, Tova Ronis, Baruch Goldberg, Ashley K. Sherman, Chelsey Smith and Gary N. Holland
    Citation: Pediatric Rheumatology 2021 19:149
  6. Intravenous immunoglobulin (IVIG) resistance prediction is one of the primary clinical issues and study hotspots in KD. This study aimed to prospectively investigate the value of albumin-bilirubin grade (ALBI)...

    Authors: Yu Yan, Lina Qiao, Yimin Hua, Shuran Shao, Nanjun Zhang, Mei Wu, Lei Liu, Kaiyu Zhou, Xiaoliang Liu and Chuan Wang
    Citation: Pediatric Rheumatology 2021 19:147
  7. Juvenile Idiopathic Inflammatory Myopathies (IIM) are a group of rare diseases that are heterogeneous in terms of pathology that can include proximal muscle weakness, associated skin changes and systemic invol...

    Authors: Meredyth G. Ll Wilkinson, Claire T. Deakin, Charalampia Papadopoulou, Despina Eleftheriou and Lucy R. Wedderburn
    Citation: Pediatric Rheumatology 2021 19:146
  8. The aetiology of juvenile idiopathic arthritis (JIA) is poorly understood. It has been shown that use of antibiotics is associated with JIA. However, whether the association is due to increased occurrence of i...

    Authors: Erik Kindgren and Johnny Ludvigsson
    Citation: Pediatric Rheumatology 2021 19:145
  9. Pleural effusion in systemic lupus erythematous (SLE) is a common symptom, and recent studies demonstrated that IL-6 has a pivotal role in its pathogenesis.

    Authors: Arianna De Matteis, Emanuela Sacco, Camilla Celani, Andrea Uva, Virginia Messia, Rebecca Nicolai, Manuela Pardeo, Fabrizio De Benedetti and Claudia Bracaglia
    Citation: Pediatric Rheumatology 2021 19:144
  10. Although canakinumab has demonstrated efficacy in multiple trials in patients with periodic fever syndromes (PFS), the evidence on initiation of canakinumab among PFS patients in real world setting is not well...

    Authors: Peter Hur, Kathleen G. Lomax, Raluca Ionescu-Ittu, Ameur M. Manceur, Jipan Xie, Jordan Cammarota, Raju Gautam, Navneet Sanghera, Nina Kim and Alexei A. Grom
    Citation: Pediatric Rheumatology 2021 19:143
  11. Autoinflammatory diseases (AID) are rare chronic conditions with high disease burden, affecting children and adults. Clinically and genetically confirmed, AID can be effectively treated with targeted cytokine ...

    Authors: Tatjana Welzel, Anna L. Wildermuth, Norbert Deschner, Susanne M. Benseler and Jasmin B. Kuemmerle-Deschner
    Citation: Pediatric Rheumatology 2021 19:142
  12. The ACR 1997, SLICC 2012 and EULAR/ACR 2019 classification criteria were validated based on adult patients. To date, there are no classification criteria specific for children with SLE. The aim of the study is...

    Authors: Reem Abdwani, Eman Al Masroori, Eiman Abdullah, Safiya Al Abrawi and Ibrahim Al-Zakwani
    Citation: Pediatric Rheumatology 2021 19:141

    The Correction to this article has been published in Pediatric Rheumatology 2021 19:165

  13. Surgeries for idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children are complex because of the high risk of inflammatory postoperative complications. There is no consensus about t...

    Authors: Julie Molimard, Christine Pajot, Priscille Olle, Alexandre Belot, Pierre Quartier, Florence Uettwiller, Chloé Couret, Valentine Coste, Camille Costet, Bahram Bodaghi, Pascal Dureau, Marion Bailhache and Pascal Pillet
    Citation: Pediatric Rheumatology 2021 19:139
  14. This case study documents the first familial case of Blau syndrome (BS) in Palestine characterized with mutation in CARD15/NOD2.

    Authors: Salam Iriqat, Mohammed Abu Safieh, Manuel Fatouleh and Abdulsalam Alkaiyat
    Citation: Pediatric Rheumatology 2021 19:138
  15. Consensus treatment plans have been developed for induction therapy of newly diagnosed proliferative lupus nephritis (LN) in childhood-onset systemic lupus erythematosus. However, patients who do not respond t...

    Authors: Mileka Gilbert, Beatrice Goilav, Joyce J. Hsu, Paul J. Nietert, Esra Meidan, Annabelle Chua, Stacy P. Ardoin, Scott E. Wenderfer, Emily von Scheven and Natasha M. Ruth
    Citation: Pediatric Rheumatology 2021 19:137
  16. The importance of developmentally appropriate transitional care in young people with juvenile-onset rheumatic and musculoskeletal disease is well recognised. The Paediatric Rheumatology European Society (PReS)...

    Authors: Janet E. McDonagh, Rachel Tattersall, Jacqui Clinch, Joanne Swan, Helen E. Foster and Liza McCann
    Citation: Pediatric Rheumatology 2021 19:136
  17. Juvenile idiopathic arthritis (JIA) is the most common paediatric rheumatological disorder and is classified by subtype according to International League of Associations for Rheumatology criteria. Depending on...

    Authors: Lina N. Zaripova, Angela Midgley, Stephen E. Christmas, Michael W. Beresford, Eileen M. Baildam and Rachel A. Oldershaw
    Citation: Pediatric Rheumatology 2021 19:135
  18. Juvenile idiopathic arthritis (JIA), is the most common pediatric rheumatologic disorder with unknown etiology. Currently, no population-based data are available regarding the distribution of categories and fr...

    Authors: Sezgin Sahin, Ceyhun Acari, Hafize Emine Sonmez, Fatma Zehra Kilic, Erdal Sag, Hatice Adiguzel Dundar, Amra Adrovic, Selcan Demir, Kenan Barut, Yelda Bilginer, Betul Sozeri, Erbil Unsal, Seza Ozen and Ozgur Kasapcopur
    Citation: Pediatric Rheumatology 2021 19:134
  19. We aimed to characterize etanercept (ETN) use in juvenile idiopathic arthritis (JIA) patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.

    Authors: Timothy Beukelman, Aimee Lougee, Roland A. Matsouaka, David Collier, Dax G. Rumsey, Jennifer Schenfeld, Scott Stryker, Marinka Twilt and Yukiko Kimura
    Citation: Pediatric Rheumatology 2021 19:131
  20. Juvenile idiopathic arthritis constitutes a significant cause of disability and quality of life impairment in pediatric and adult patients. The aim of this study was to ascertain clinical remission (CR) and su...

    Authors: Mireia Castillo-Vilella, Nuria Giménez, Jose Luis Tandaipan, Salvador Quintana and Consuelo Modesto
    Citation: Pediatric Rheumatology 2021 19:130
  21. The curriculum for professionals working in paediatric rheumatology should include pain but it is unclear to what extent this currently occurs. The aim of this study was to identify pain-related curriculum con...

    Authors: Rebecca Rachael Lee, Janet E. McDonagh, Mark Connelly, Sarah Peters and Lis Cordingley
    Citation: Pediatric Rheumatology 2021 19:129
  22. Juvenile-onset Fibromyalgia (JFM) is a chronic pain condition characterized by widespread musculoskeletal pain, fatigue, sleep difficulties, mood concerns, and other associated symptoms. Although diagnosed in ...

    Authors: Morgan Daffin, Mary K. Lynch-Milder, Robert C. Gibler, Caitlin Murray, Carly M. Green and Susmita Kashikar-Zuck
    Citation: Pediatric Rheumatology 2021 19:128
  23. High-intensity glucocorticoid regimens are commonly used to induce and maintain remission in Juvenile Dermatomyositis but are associated with several adverse side-effects. Evidence-based treatment guidelines f...

    Authors: Amir B. Orandi, Lampros Fotis, Jamie Lai, Hallie Morris, Andrew J. White, Anthony R. French and Kevin W. Baszis
    Citation: Pediatric Rheumatology 2021 19:127
  24. Mutations along PSTPIP1 gene are associated to two specific conditions, PAPA syndrome and PAMI syndrome, both autoinflammatory disorders associated to disturbances in cytoskeleton formation. Immunological aspe...

    Authors: Leonardo Oliveira Mendonça, Maria Teresa Terreri, Fabiane Mitie Osaku, Samar Freschi Barros, Karen Francine Köhler, Alex Isidoro Prado, Myrthes Toledo Barros, Jorge Kalil and Fabio Fernandes Morato Castro
    Citation: Pediatric Rheumatology 2021 19:126
  25. Based on the recently developed ChRonic nonbacterial Osteomyelitis MRI Scoring tool (CROMRIS), we developed a radiological activity index (RAI-CROMRIS) to obtain a quantification of the overall bone involvemen...

    Authors: Martina Capponi, Denise Pires Marafon, Flaminia Rivosecchi, Yongdong Zhao, Manuela Pardeo, Virginia Messia, Laura Tanturri de Horatio, Paolo Tomà, Fabrizio De Benedetti and Antonella Insalaco
    Citation: Pediatric Rheumatology 2021 19:123
  26. The impact of social determinants of health on children with polyarticular juvenile idiopathic arthritis (pJIA) is poorly understood. Prompt initiation of treatment for pJIA is important to prevent disease mor...

    Authors: Nayimisha Balmuri, William Daniel Soulsby, Victoria Cooley, Linda Gerber, Erica Lawson, Susan Goodman, Karen Onel and Bella Mehta
    Citation: Pediatric Rheumatology 2021 19:122
  27. Mendelian susceptibility to mycobacterial disease (MSMD) is an inborn error of immunity, resulting in susceptibility to weakly virulent mycobacteria and other intramacrophagic pathogens. Rheumatologic manifest...

    Authors: Niusha Sharifinejad, Seyed Alireza Mahdaviani, Mahnaz Jamee, Zahra Daneshmandi, Afshin Moniri, Majid Marjani, Payam Tabarsi, Parisa Farnia, Mahsa Rekabi, Mazdak Fallahi, Seyedeh Atefeh Hashemimoghaddam, Masoumeh Mohkam, Jacinta Bustamante, Jean-Laurent Casanova, Davood Mansouri and Ali Akbar Velayati
    Citation: Pediatric Rheumatology 2021 19:121
  28. High-dose glucocorticoids (GC) remain the primary therapy to induce remission in Juvenile Dermatomyositis (JDM). Studies of the natural history of GC associated weight gain in children are very limited, especi...

    Authors: Amer Khojah, Victoria Liu, Gabrielle Morgan, Richard M. Shore and Lauren M. Pachman
    Citation: Pediatric Rheumatology 2021 19:118
  29. To describe a case of pediatric sarcoidosis which initially presented as papillary conjunctivitis before manifesting as bilateral lacrimal gland swelling without other known systemic involvement.

    Authors: Margaret S. Powell, Ashley W. Cross, Jared Tallo, Edward W. Cheeseman and Mileka R. Gilbert
    Citation: Pediatric Rheumatology 2021 19:117
  30. Despite being at high risk for depression, patients with childhood-onset systemic lupus erythematosus (c-SLE) are infrequently and inconsistently screened for depression by their pediatric rheumatologists. We ...

    Authors: Evan Mulvihill, Rebecca Furru, Alana Goldstein-Leever, Kyla Driest, Stephanie Lemle, Darby MacDonald, Emily Frost and Vidya Sivaraman
    Citation: Pediatric Rheumatology 2021 19:116

    The Correction to this article has been published in Pediatric Rheumatology 2021 19:133

  31. Authors: Francesco Baldo, Michela Brena, Simone Carbogno, Francesca Minoia, Stefano Lanni, Sophie Guez, Antonella Petaccia, Carlo Agostoni, Rolando Cimaz and Giovanni Filocamo
    Citation: Pediatric Rheumatology 2021 19:115

    The original article was published in Pediatric Rheumatology 2021 19:80

  32. Respiratory conditions are the leading cause of hospitalization and death in children with Trisomy 21 (T21). Diffuse alveolar hemorrhage (DAH) occurs at higher frequency in children with T21; yet, it is not wi...

    Authors: Jessica L. Bloom, Benjamin Frank, Jason P. Weinman, Csaba Galambos, Sean T. O’Leary, Deborah R. Liptzin and Robert C. Fuhlbrigge
    Citation: Pediatric Rheumatology 2021 19:114
  33. Despite the commonality of adolescent knee pain, there are no tools to support medical doctors to correctly diagnose knee pain. This study aimed to develop and evaluate a support tool for diagnosing the most c...

    Authors: Clara Guldhammer, Sinead Holden, Marina Elmelund Sørensen, Jens Lykkegaard Olesen, Martin Bach Jensen and Michael Skovdal Rathleff
    Citation: Pediatric Rheumatology 2021 19:110
  34. Glucocorticoid exposure is a significant driver of morbidity in children with systemic juvenile idiopathic arthritis (sJIA). We determined the effect of early initiation of biologic therapy (IL-1 or IL-6 inhib...

    Authors: Rosemary G. Peterson, Rui Xiao, Hannah Katcoff, Brian T. Fisher and Pamela F. Weiss
    Citation: Pediatric Rheumatology 2021 19:109
  35. Immunosuppressive drugs, incomplete vaccine coverage, immune system dysregulation might be factors of a low level of anti-vaccine antibodies in JIA patients. The study aimed to evaluate vaccine coverage, post-...

    Authors: Mikhail M. Kostik, Natalia A. Lubimova, Irina V. Fridman, Olga V. Goleva and Susanna M. Kharit
    Citation: Pediatric Rheumatology 2021 19:108
  36. High-dose intravenous immunoglobulin (IVIG) is the mainstay of treatment for Kawasaki disease (KD). Usually, 2 g/kg of IVIG is administered over 10–24 h, depending on the institution or physician, but the asso...

    Authors: Saori Fukui, Mitsuru Seki, Takaomi Minami, Kazuhiko Kotani, Kensuke Oka, Akiko Yokomizo, Daisuke Matsubara, Tomoyuki Sato, Yasuyuki Nozaki, Mari Saito, Yutaka Kikuchi, Kenji Miyamoto, Yukifumi Monden and Takanori Yamagata
    Citation: Pediatric Rheumatology 2021 19:107
  37. Recognition of temporomandibular joint (TMJ) involvement in children with juvenile idiopathic arthritis (JIA) has gained increasing attention in the past decade. The clinical assessment of mandibular range of ...

    Authors: Willemijn F. C. de Sonnaville, Caroline M. Speksnijder, Nicolaas P. A. Zuithoff, Daan R. C. Verkouteren, Nico W. Wulffraat, Michel H. Steenks and Antoine J. W. P. Rosenberg
    Citation: Pediatric Rheumatology 2021 19:106

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    3.0 - 5-year Impact Factor
    1.035 - SNIP (Source Normalized Impact per Paper)
    0.732 - SJR (SCImago Journal Rank)

    2023 Speed
    18 days submission to first editorial decision for all manuscripts (Median)
    94 days submission to accept (Median)

    2023 Usage 
    1,095,144 downloads
    691 Altmetric mentions